Figure 2.

Prevalence of pituitary antibodies reported dichotomously as present or absent in the current study (left panels) and in previously published studies (right panels). A, Prevalence in our cohort of 60 healthy controls and 390 patients. B, Summary of the studies published from 1969 to 2013 using pituitary gland as substrate for the immunofluorescence assays. C, Prevalence in our cohort of patients with pituitary diseases according to the diagnostic category. D, Results in published literature according to diagnostic categories. Bold numbers underneath each box in D indicate the number of studies. Numbers above the graphs indicate the total number of patients that were studied and how many had positive pituitary antibodies by IIF. Abbreviations: BP, biopsy proven; CS, clinically suspected; DI, diabetes insipidus; SMOUP, sellar masses of unknown pathology.